SCHEMBL30557883

SCHEMBL30557883

CCCCCC[N+]1(C)CCCCC1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.42
KMT2A Q03164 1/20 0.42
APOBEC3A P31941 2/20 0.39
APOBEC3G Q9HC16 2/20 0.39
CYP3A4 P08684 1/20 0.36
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
BLM P54132 1/20 0.36
PMP22 Q01453 1/20 0.36
GNAI3 P08754 1/20 0.36
GNAO1 P09471 1/20 0.36
GNAI1 P63096 1/20 0.36
BBOX1 O75936 2/20 0.36
EPHX1 P07099 1/20 0.35
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
CHRM5 P08912 1/20 0.31
CHRM1 P11229 1/20 0.31
CHRM3 P20309 1/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31411021 1.00 LMNA (0.42) LMNAKMT2AAPOBEC3AAPOBEC3GCYP3A4
SCHEMBL31411033 1.00 LMNA (0.42) LMNAKMT2AAPOBEC3AAPOBEC3GCYP3A4
SCHEMBL30557891 1.00 LMNA (0.42) LMNAKMT2AAPOBEC3AAPOBEC3GCYP3A4
SCHEMBL31411028 0.98 LMNA (0.40) LMNAKMT2AAPOBEC3AAPOBEC3GCYP3A4
SCHEMBL30183054 0.98 LMNA (0.40) LMNAKMT2AAPOBEC3AAPOBEC3GCYP3A4
SCHEMBL30557879 0.98 LMNA (0.40) LMNAKMT2AAPOBEC3AAPOBEC3GCYP3A4
SCHEMBL31121673 0.98 LMNA (0.40) LMNAKMT2AAPOBEC3AAPOBEC3GCYP3A4
SCHEMBL30069394 0.98 LMNA (0.40) LMNAKMT2AAPOBEC3AAPOBEC3GCYP3A4
SCHEMBL30014585 0.97 LMNA (0.38) LMNAKMT2AAPOBEC3AAPOBEC3GCYP3A4
SCHEMBL3452819 0.94 LMNA (0.38) LMNAKMT2AAPOBEC3AAPOBEC3GCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260133459-A1 LOW-TEMPERATURE SOLID POLYMER ELECTROLYTE FOR ELECTROCHROMIC DEVICES LANNRAY ADVANCED MAT CO LTD (CN) 2026-05-14 US claimed
US-20260133459-A1 LOW-TEMPERATURE SOLID POLYMER ELECTROLYTE FOR ELECTROCHROMIC DEVICES LANNRAY ADVANCED MAT CO LTD (CN) 2026-05-14 US disclosed
WO-2025079674-A1 THERMOPLASTIC RESIN COMPOSITION 東洋紡株式会社 2025-04-17 WO disclosed
CN-118496778-A Pressure-sensitive adhesive sheet 日东电工(上海松江)有限公司 2024-08-16 CN disclosed
CN-116769409-A Pressure-sensitive adhesive sheet 日东电工(上海松江)有限公司 2023-09-19 CN disclosed
CN-116769408-A Pressure-sensitive adhesive sheet 日东电工(上海松江)有限公司 2023-09-19 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260133459-A1 LOW-TEMPERATURE SOLID POLYMER ELECTROLYTE FOR ELECTROCHROMIC DEVICES EEF2, PHF2, EIF4E LMNA 3927/4885KMT2A 463/4885APOBEC3A 1139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.